ORIGINAL RESEARCH
Published on 16 Oct 2023
Therapeutic efficacy of omalizumab in children with moderate-to-severe allergic asthma combined with chronic sinusitis
doi 10.3389/falgy.2023.1236798
- 1,032 views
- 3 citations
- Frontiers in Allergy
- Asthma
- Research Topics
- Criteria to Be Considered in the Selection of Biological Agents Used in Severe Asthma
Criteria to Be Considered in the Selection of Biological Agents Used in Severe Asthma
6,002
Total downloads
22k
Total views and downloads
Articles
REVIEW
Published on 30 May 2023
The role of the respiratory microbiome in asthma
doi 10.3389/falgy.2023.1120999
- 5,942 views
- 17 citations
ORIGINAL RESEARCH
Published on 12 Apr 2023
Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study
doi 10.3389/fimmu.2023.1150162
- 11,740 views
- 62 citations
CORRECTION
Published on 10 Jan 2023
Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach
doi 10.3389/falgy.2022.1119941
- 777 views
BRIEF RESEARCH REPORT
Published on 04 Jan 2023
Real-World clinical outcomes of asthma patients switched from reslizumab to mepolizumab or benralizumab
doi 10.3389/falgy.2022.1052339
- 1,473 views
